Вже доступно! Дослідження Telegram за 2025 — головні інсайти року 
JAMA (Journal of the American Medical Association)
Відкрити в Telegram
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Показати більше📈 Аналітичний огляд Telegram-каналу JAMA (Journal of the American Medical Association)
Канал JAMA (Journal of the American Medical Association) (@jamaupdates) у мовному сегменті Англійська є активним учасником. На даний момент спільнота об'єднує 15 439 підписників, посідаючи 1 575 місце в категорії Медицина та 2 467 місце у регіоні США.
📊 Показники аудиторії та динаміка
З моменту свого створення невідомо, проект продемонстрував стрімке зростання, зібравши аудиторію у 15 439 підписників.
За останніми даними від 30 червня, 2026, канал демонструє стабільну активність. Хоча за останні 30 днів спостерігається зміна кількості учасників на 420, а за останні 24 години на 11, загальне охоплення залишається високим.
- Статус верифікації: Не верифікований
- Рівень залученості (ER): Середній показник залученості аудиторії становить 4.77%. Протягом перших 24 годин після публікації контент зазвичай збирає 1.99% реакцій від загальної кількості підписників.
- Охоплення публікацій: В середньому кожен допис отримує 736 переглядів. Протягом першої доби публікація в середньому набирає 307 переглядів.
- Реакції та взаємодія: Аудиторія активно підтримує контент: середня кількість реакцій на один пост – 1.
- Тематичні інтереси: Контент зосереджений навколо ключових тем, таких як patient, disease, treatment, drug, guideline.
📝 Опис та контентна політика
Автор описує ресурс як майданчик для висловлення суб'єктивної думки:
“All the latest articles published on JAMA before going in to print
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot”
Завдяки високій частоті оновлень (останні дані отримано 01 липня, 2026), канал підтримує актуальність та високий рівень охоплення публікацій. Аналітика показує, що аудиторія активно взаємодіє з контентом, що робить його важливою точкою впливу в категорії Медицина.
15 439
Підписники
+1124 години
+967 днів
+42030 день
Триває завантаження даних...
Схожі канали
Хмара тегів
Вхідні та вихідні згадування
---
---
---
---
---
---
Залучення підписників
липень '26
липень '26
+5
в 0 каналах
червень '26
+422
в 0 каналах
Get PRO
травень '26
+584
в 0 каналах
Get PRO
квітень '26
+437
в 0 каналах
Get PRO
березень '26
+217
в 0 каналах
Get PRO
лютий '26
+247
в 0 каналах
Get PRO
січень '26
+321
в 0 каналах
Get PRO
грудень '25
+277
в 0 каналах
Get PRO
листопад '25
+366
в 2 каналах
Get PRO
жовтень '25
+164
в 0 каналах
Get PRO
вересень '25
+12
в 0 каналах
Get PRO
серпень '25
+29
в 0 каналах
Get PRO
липень '25
+30
в 0 каналах
Get PRO
червень '25
+17
в 0 каналах
Get PRO
травень '25
+9
в 0 каналах
Get PRO
квітень '25
+5
в 0 каналах
Get PRO
березень '25
+17
в 0 каналах
Get PRO
лютий '25
+12
в 0 каналах
Get PRO
січень '25
+18
в 1 каналах
Get PRO
грудень '24
+237
в 0 каналах
Get PRO
листопад '24
+1 122
в 0 каналах
Get PRO
жовтень '24
+1 120
в 0 каналах
Get PRO
вересень '24
+1 527
в 1 каналах
Get PRO
серпень '24
+1 128
в 1 каналах
Get PRO
липень '24
+1 216
в 0 каналах
Get PRO
червень '24
+781
в 1 каналах
Get PRO
травень '24
+797
в 1 каналах
Get PRO
квітень '24
+808
в 1 каналах
Get PRO
березень '24
+821
в 2 каналах
Get PRO
лютий '24
+753
в 1 каналах
Get PRO
січень '24
+768
в 0 каналах
Get PRO
грудень '23
+716
в 1 каналах
Get PRO
листопад '23
+96
в 1 каналах
Get PRO
жовтень '23
+86
в 0 каналах
Get PRO
вересень '23
+73
в 0 каналах
Get PRO
серпень '23
+90
в 0 каналах
Get PRO
липень '23
+107
в 0 каналах
Get PRO
червень '23
+105
в 0 каналах
Get PRO
травень '23
+169
в 0 каналах
Get PRO
квітень '23
+128
в 0 каналах
Get PRO
березень '23
+84
в 0 каналах
Get PRO
лютий '23
+75
в 0 каналах
Get PRO
січень '23
+71
в 0 каналах
Get PRO
грудень '22
+74
в 0 каналах
Get PRO
листопад '22
+149
в 0 каналах
Get PRO
жовтень '22
+90
в 0 каналах
Get PRO
вересень '22
+138
в 0 каналах
Get PRO
серпень '22
+77
в 0 каналах
Get PRO
липень '22
+50
в 0 каналах
Get PRO
червень '22
+96
в 0 каналах
Get PRO
травень '22
+75
в 0 каналах
Get PRO
квітень '22
+80
в 0 каналах
Get PRO
березень '22
+65
в 0 каналах
Get PRO
лютий '22
+26
в 0 каналах
Get PRO
січень '22
+56
в 0 каналах
Get PRO
грудень '21
+44
в 0 каналах
Get PRO
листопад '21
+39
в 0 каналах
Get PRO
жовтень '21
+61
в 0 каналах
Get PRO
вересень '21
+66
в 0 каналах
Get PRO
серпень '21
+65
в 0 каналах
Get PRO
липень '21
+96
в 0 каналах
Get PRO
червень '21
+120
в 0 каналах
Get PRO
травень '21
+130
в 0 каналах
Get PRO
квітень '21
+812
в 0 каналах
| Дата | Залучення підписників | Згадування | Канали | |
| 01 липня | +5 |
Дописи каналу
Health Equity: JAMA Internal Medicine Call for Papers
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851086
Research on health differences by social class and economic status dates back to the mid-19th century. Early European publications examined differences in health by social class; then, during the next 100 years, the US produced the bulk of the evidence describing persistent and substantive differences in health across a broader range of social factors. During this descriptive period, scientists and clinicians came to realize that the differences noted in health care settings resulted from an array of structural, environmental, and social factors that spanned well beyond individual patients or the health care system. These broader factors are directly related to historical and current systemic inequities disadvantaging multiple population groups. The US is a fitting setting for this descriptive work, given its particularly stark social and economic inequities despite unparalleled national spending on research and health care. More recently, this research has evolved to explore underlying mechanisms of inequities and to test interventions to improve outcomes. This evolution has also marked a shift in nomenclature from health disparities (descriptive) to health equity (advancing health for all) research. However, despite progress during the last 75 years in the US, research in this field has continued to focus overwhelmingly on describing the number and scope of health inequities and defining the groups most adversely affected, at times relying heavily on conjectures about underlying etiology framed by the sociopolitical context.
| 2 | Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2850980
In September 2025, the US administration held a press conference stating that its ongoing investigation into the causes of autism had identified maternal use of acetaminophen (paracetamol) during pregnancy as a potential causal factor. This was concerning given that acetaminophen is among the most used medications in pregnancy for the management of pain and fever, in part because alternative options are limited or contraindicated (eg, nonsteroidal anti-inflammatory medications and opioids). | 546 |
| 3 | Expanding Access to Mindfulness for Pain
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2850981
Back pain is among the most widespread and disabling conditions treated in primary care in the US, yet its management remains challenging and costly. Untreated and undertreated chronic low back pain (cLBP) has left many patients without adequate relief, contributing to the overprescribing and overuse of opioids and other medications, despite known adverse effects and risks of dependence and overdose. Guidelines for treating cLBP now recommend evidence-based nonpharmacologic pain treatments, including complementary and integrative health approaches, of which mindfulness-based interventions are among the most popular. Mindfulness-based interventions are especially well suited for treating cLBP, with evidence that they can improve common co-occurring conditions, such as depression, anxiety, and sleep disorders, that can contribute to and exacerbate pain. However, mindfulness and other complementary and integrative health approaches remain underused, partially because of the difficulties in integrating them into usual clinical practice. | 514 |
| 4 | Texting in Health Care
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2850974
This Viewpoint offers strategies to help ensure that health care text messaging remains impactful rather than intrusive for patients. | 378 |
| 5 | Wide-Complex Tachycardia With Diffuse ST-Segment Elevation
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2850982
This case report describes the electrocardiogram findings of an older adult man with acute chest pain, dyspnea, and altered consciousness. | 369 |
| 6 | In Defense of Novel Autoantibody Discovery
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850849
This Viewpoint discusses the discovery of numerous neuronal autoantibodies and how autoimmune encephalitis is diagnosed and treated. | 401 |
| 7 | Novel Autoantibody Discovery in Encephalitis
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850850
This Viewpoint describes a plateau in the discovery of clinically meaningful autoantibodies in autoimmune encephalitis (AE) and suggests efforts that are likely to offer greater benefits to patients living with AE. | 430 |
| 8 | Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850851
This diagnostic study investigates the accuracy of the plasma phosphorylated tau 217 (p-tau217)/amyloid-β 42 (Aβ42) ratio test for detecting amyloid–positron emission tomography positivity for an Alzheimer disease diagnosis in older veterans with and without a history of traumatic brain injury. | 445 |
| 9 | Superficial Siderosis and a Spinal Cord Cleft
https://jamanetwork.com/journals/jamaneurology/fullarticle/2850852
This case report describes a 71-year-old woman presenting with altered speech, gait difficulties, and hearing loss diagnosed with infratentorial superficial siderosis and a thoracic spinal cord cleft. | 425 |
| 10 | Insufficient Sleep Among US Adolescents—Reply
https://jamanetwork.com/journals/jama/fullarticle/2850723
In Reply In his thoughtful comments on our Research Letter examining trends in insufficient sleep among US adolescents, Dr White raises an important point regarding the comparability of the 2021 and 2023 screen time measures with those used in prior years (2007-2019). | 947 |
| 11 | Primary Composite Outcome Corrected in a Trial of Transfusion Strategy
https://jamanetwork.com/journals/jama/fullarticle/2850724
To the Editor We wish to report corrections to our study of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia. During secondary analyses of the trial results related to heart failure, it became apparent that the original analysis of the primary composite outcome had mistakenly included heart failure events as a component of the primary outcome (although heart failure events were adjudicated, they were not part of the prespecified primary composite outcome, which included all-cause death, stroke, recurrent myocardial infarction, or emergency revascularization prompted by ischemia at 30 days). In addition, the date of consent withdrawal was recorded incorrectly for 4 patients (before 30 days rather than after 30 days). Thus, as specified in the protocol and statistical analysis plan, they should have been considered missing, but had been coded as “no event.” | 875 |
| 12 | Insufficient Sleep Among US Adolescents
https://jamanetwork.com/journals/jama/fullarticle/2850725
To the Editor A recent Research Letter examined trends in adolescent sleep using biennial Youth Risk Behavior Survey (YRBS) data from 2007 to 2023. For most of that period, the relevant YRBS question items are nearly identical, with 1 notable exception. The screen-time question in the 2023 YRBS is substantially different from the screen time questions used in prior years. From 2007 through 2019, the YRBS asked “On the average school day, how many hours do you play video or computer games or use a computer for something that is not school work? (Include activities such as Nintendo, Game Boy, PlayStation, Xbox, computer games, and the internet).” The examples provided in parentheses changed over time, with later iterations of the YRBS citing examples such as social media, texting, and tablet use. However, the underlying construct remained largely unchanged. In contrast, the only screen-related question item in the 2023 YRBS was “How often do you use social media?” In this case, respondents were asked to give a frequency-based response (eg, “A few times a month,” “Several times a day,” etc) rather than an estimate of hours. | 585 |
| 13 | End-of-Life and Hospice Care for People Who Are Incarcerated
https://jamanetwork.com/journals/jama/fullarticle/2850726
This JAMA Insights discusses the need to expand prison hospice and compassionate release and enrich clinician understanding of the needs of dying patients who are incarcerated to provide compassionate and appropriate end-of-life care. | 482 |
| 14 | Correction to Primary Composite Outcome in a Trial of Transfusion Strategy
https://jamanetwork.com/journals/jama/fullarticle/2850727
The Original Investigation titled “Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial” published February 9, 2021, was corrected to fix the number of events for the primary outcome. Calculation of the primary composite outcome had mistakenly included heart failure events as a component, and the date of consent withdrawal was recorded incorrectly for 4 patients (before 30 days rather than after 30 days). Thus, as specified in the protocol and statistical analysis plan, they should have been considered missing, but had been coded as “no event.” After correction, the number of events for the primary outcome is slightly lower than in the original analysis (29 vs 36 for the restrictive transfusion group and 36 vs 45 for the liberal group). This change does not impact the main conclusion: the restrictive strategy resulted in a noninferior rate of major adverse cardiovascular events after 30 days compared with the liberal strategy. This article has been corrected online; a letter of explanation appears in this issue. | 534 |
| 15 | Seven-Year Valve Durability With TAVR
https://jamanetwork.com/journals/jamacardiology/fullarticle/2850866
This ad hoc analysis of a randomized clinical trial reports on the 7-year outcomes among a group of low-risk patients with symptomatic severe aortic stenosis treated with transcatheter aortic valve replacement vs surgery. | 558 |
| 16 | Toward a Lifetime Strategy for Aortic Valve Replacement—Ariadne’s Thread
https://jamanetwork.com/journals/jamacardiology/fullarticle/2850867
The expansion of transcatheter aortic valve replacement (TAVR) into younger and lower-risk populations has fundamentally reshaped the central question in the management of aortic stenosis (AS). Procedural safety and early outcomes are no longer the dominant concerns. Instead, the focus has shifted toward durability and, more importantly, toward how the initial intervention fits within a lifetime treatment strategy. In this context, the 7-year durability analysis from the Placement of Aortic Transcatheter Valves 3 (PARTNER 3) randomized clinical trial provides reassuring comparative results. | 600 |
| 17 | Evidence. Education. Better Care.
Latest medical research, guideline updates, and news—all in one place.
https://whatsapp.com/channel/0029VagObEL3rZZbSTrZSU03 | 680 |
| 18 | Stopping Alzheimer Disease
https://jamanetwork.com/journals/jama/fullarticle/2850604
This Perspective discusses progress made in Alzheimer disease prevention during the last 50 years. | 729 |
| 19 | Trends in Newborn Hepatitis B Virus Vaccination—Reply
https://jamanetwork.com/journals/jama/fullarticle/2850605
In Reply We appreciate the thoughtful comments of Dr Dysart and colleagues regarding our Research Letter on US newborn HBV vaccination rates. Their observations highlight important considerations for research using aggregated electronic health record data, and we welcome the opportunity to clarify several methodological points. | 704 |
| 20 | Trends in Newborn Hepatitis B Virus Vaccination
https://jamanetwork.com/journals/jama/fullarticle/2850606
To the Editor Dr Rothman and colleagues reported trends in newborn hepatitis B virus (HBV) vaccination in Epic Cosmos, a large-scale electronic health record database. They found that vaccinations rose from 67.5% in January 2017, peaked at 83.5% in February 2023, and then declined to 73.2% in August 2025. As pediatricians and neonatologists who observe HBV vaccine declination, we applaud the authors for quantifying this public health issue. | 611 |
